Autor:	SIM, SHUAN (AUTHOR)
Předmět:	LIFE sciences, TAX credits, SCIENCE & industry, URBAN life
Zdroj:	Crain's New York Business. 3/14/2022, Vol. 38 Issue 10, p1-1. 1p.
Abstrakt:	"It's quite apparent the life science industry and equity markets are going through a new bout of volatility", said Matthew Price, executive vice president and chief operating officer of Phosplatin, a Midtown-based biotech firm focused on oncology therapeutics. Although this tax change affects all industries, it has an acute impact on life science firms, especially precommercial ones, where R&D expenses can make up more than 90% of their income statements. [Extracted from the article]
Databáze:	Regional Business News
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.